Epigenetic mechanisms and cancer: An interface between the environment and the genome

Although epidemiological studies support the role of environment in a wide range of human cancers, the precise mechanisms by which environmental exposures promote cancer development and progression remain poorly understood. Environmental factors have been proposed to promote the development of malignancies by eliciting epigenetic changes; however, it is only with recent advances in epigenetics and epigenomics that target genes and the mechanisms underlying environmental influences are beginning to be elucidated. Because epigenetic mechanisms may function as an interface between environmental factors and the genome, deregulation of the epigenome by environmental stressors is likely to disrupt different cellular processes and contribute to cancer risk. In addition, the early appearance and ubiquity of epigenetic changes in virtually all steps of tumor development and progression in most, if not all, human neoplasms, make them attractive targets for biomarker discovery and targeted prevention. At the cellular level, aberrant epigenetic changes associated with environmental exposures may deregulate key cellular processes (including transcriptional control, DNA repair, cell cycle control, and carcinogen detoxification), which can be further modulated by environmental stressors, thus defining not only the phenotype of the disease but also potential biomarkers. This review summarizes recent progress in our understanding of the epigenetic mechanisms through which environmental factors may promote tumor development, with a particular focus on human lung cancer.

[1]  M. Franchina,et al.  Evidence that cytosine residues within 5'-CCTGG-3' pentanucleotides can be methylated in human DNA independently of the methylating system that modifies 5'-CG-3' dinucleotides. , 2000, DNA and cell biology.

[2]  Rudolf Jaenisch,et al.  Synergism of Xist Rna, DNA Methylation, and Histone Hypoacetylation in Maintaining X Chromosome Inactivation , 2001, The Journal of cell biology.

[3]  T. Byers,et al.  Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. , 2010, Cancer research.

[4]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[5]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[6]  M. Esteller Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[7]  K. Schuebel,et al.  De novo CpG island methylation in human cancer cells. , 2006, Cancer research.

[8]  M. Robert,et al.  An Essential Role for DNA Methyltransferase DNMT3B in Cancer Cell Survival* , 2002, The Journal of Biological Chemistry.

[9]  J. P. Jackson,et al.  CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Satoshi Tanaka,et al.  Non-coding RNA directed DNA demethylation of Sphk1 CpG island. , 2004, Biochemical and biophysical research communications.

[11]  M. Pellegrini,et al.  Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency , 2010, Nature.

[12]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[13]  E. Ballestar,et al.  Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation , 1999, Nature Genetics.

[14]  F. Clavel-Chapelon,et al.  Serum B vitamin levels and risk of lung cancer. , 2010, JAMA.

[15]  M. T. McCabe,et al.  A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation. , 2009, Cancer research.

[16]  A. Riggs,et al.  Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay , 2007, Proceedings of the National Academy of Sciences.

[17]  O. Stanger Physiology of folic acid in health and disease. , 2002, Current drug metabolism.

[18]  清家 正博 Increase in the frequency of p16[INK4] gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53 , 2002 .

[19]  K. Robertson,et al.  Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer , 2007, Oncogene.

[20]  M. Esteller CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[21]  C. Moon,et al.  Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung Cancer , 2004, Clinical Cancer Research.

[22]  David I. K. Martin,et al.  Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue , 2004, International Journal of Colorectal Disease.

[23]  A. Wolffe,et al.  Chromatin remodeling: why it is important in cancer , 2001, Oncogene.

[24]  J. Herman,et al.  In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Hoffmann,et al.  A Unifying Model for the Selective Regulation of Inducible Transcription by CpG Islands and Nucleosome Remodeling , 2009, Cell.

[26]  W. Gerald,et al.  Epigenetic lesions at the H19 locus in Wilms' tumour patients , 1994, Nature Genetics.

[27]  Edward Gabrielson,et al.  Hypermethylation of the GATA Genes in Lung Cancer , 2004, Clinical Cancer Research.

[28]  A. Shilatifard,et al.  An operational definition of epigenetics. , 2009, Genes & development.

[29]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[30]  Yi Zhang,et al.  Dnmt3a-Dependent Nonpromoter DNA Methylation Facilitates Transcription of Neurogenic Genes , 2010, Science.

[31]  S Ramchandani,et al.  DNA methylation is a reversible biological signal. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Jeltsch,et al.  Structure and Function of Mammalian DNA Methyltransferases , 2011, Chembiochem : a European journal of chemical biology.

[33]  F. Khuri,et al.  Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. , 2000, Journal of the National Cancer Institute.

[34]  Z. Herceg,et al.  Epigenetic interplay between histone modifications and DNA methylation in gene silencing. , 2008, Mutation research.

[35]  J. Herman,et al.  Predicting lung cancer by detecting aberrant promoter methylation in sputum. , 2000, Cancer research.

[36]  M. Siegmann,et al.  Mechanisms of DNA Demethylation in Chicken Embryos , 1995, The Journal of Biological Chemistry.

[37]  J. Boer,et al.  A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. , 2003, Cancer research.

[38]  A. Kraus,et al.  Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  H. Putter,et al.  DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. , 2009, Human molecular genetics.

[40]  S. Anttila,et al.  Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer , 2003, International journal of cancer.

[41]  M. Schaefer,et al.  The Drosophila Cytosine-5 Methyltransferase Dnmt2 Is Associated with the Nuclear Matrix and Can Access DNA during Mitosis , 2008, PloS one.

[42]  Jian‐Kang Zhu Active DNA demethylation mediated by DNA glycosylases. , 2009, Annual review of genetics.

[43]  Paul Tempst,et al.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex , 1999, Nature Genetics.

[44]  A. Bird,et al.  Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Vladimir Benes,et al.  Transient cyclical methylation of promoter DNA , 2008, Nature.

[46]  M. Grillo,et al.  S-adenosylmethionine and its products , 2008, Amino Acids.

[47]  R. Jaenisch,et al.  Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. , 2007, Genes & development.

[48]  Peter A. Jones,et al.  A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. , 2005, Cancer research.

[49]  J. Issa CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.

[50]  Xiang-Jiao Yang The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. , 2004, Nucleic acids research.

[51]  Hong Duan,et al.  Role for DNA methylation in the control of cell type–specific maspin expression , 2002, Nature Genetics.

[52]  D. Albanes,et al.  Association of the B-vitamins pyridoxal 5'-phosphate (B(6)), B(12), and folate with lung cancer risk in older men. , 2001, American journal of epidemiology.

[53]  R. R. Ariza,et al.  DEMETER and REPRESSOR OF SILENCING 1 encode 5-methylcytosine DNA glycosylases. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[54]  G. Pfeifer,et al.  Methylation of the Tumor Suppressor Gene RASSF1A in Human Tumors , 2005, Biochemistry (Moscow).

[55]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[56]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[57]  Hao Wu,et al.  Epigenetic Regulation of Stem Cell Differentiation , 2006, Pediatric Research.

[58]  R. Jaenisch Human cloning - the science and ethics of nuclear transplantation. , 2004, The New England journal of medicine.

[59]  Richard Doll,et al.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.

[60]  I. Simon,et al.  Evidence for an instructive mechanism of de novo methylation in cancer cells , 2006, Nature Genetics.

[61]  Tony Kouzarides,et al.  Reversing histone methylation , 2005, Nature.

[62]  Albert Jeltsch,et al.  Cyclical DNA methylation of a transcriptionally active promoter , 2008, Nature.

[63]  Paolo Vineis,et al.  DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study , 2011, Epigenetics.

[64]  M. Robert,et al.  DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells , 2003, Nature Genetics.

[65]  S. Henikoff,et al.  DNA demethylation in the Arabidopsis genome , 2007, Proceedings of the National Academy of Sciences.

[66]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[67]  C. Bloomfield,et al.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.

[68]  T. Bestor The host defence function of genomic methylation patterns. , 1998, Novartis Foundation symposium.

[69]  J. Herman,et al.  Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia , 2001, Oncogene.

[70]  P. Laird Principles and challenges of genome-wide DNA methylation analysis , 2010, Nature Reviews Genetics.

[71]  C. Plass,et al.  DNA motifs associated with aberrant CpG island methylation. , 2006, Genomics.

[72]  J. Herman,et al.  GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric Cancer , 2003, Molecular and Cellular Biology.

[73]  M. Lipkin,et al.  Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms , 2003, Nature Reviews Cancer.

[74]  M. Surani,et al.  Genome-Wide Reprogramming in the Mouse Germ Line Entails the Base Excision Repair Pathway , 2010, Science.

[75]  Julian Peto,et al.  Cancer epidemiology in the last century and the next decade , 2001, Nature.

[76]  W. Reik,et al.  Dissecting de novo methylation , 1999, Nature Genetics.

[77]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[78]  Paolo Boffetta,et al.  Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. , 2009, Cancer research.

[79]  C. Marsit,et al.  Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma , 2006, International journal of cancer.

[80]  Ioannis Panagopoulos,et al.  Promoter analysis of epigenetically controlled genes in bladder cancer , 2008, Genes, chromosomes & cancer.

[81]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[82]  S. Lehnert,et al.  Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. , 1987, Development.

[83]  P. Vineis,et al.  Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids , 2009, Epigenetics.

[84]  R. Singal,et al.  Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity. , 2009, Anticancer research.

[85]  M. Fraga,et al.  DNA methyltransferases control telomere length and telomere recombination in mammalian cells , 2006, Nature Cell Biology.

[86]  A. Bird DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[87]  M. Gruidl,et al.  CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis. , 2005, Cancer biomarkers : section A of Disease markers.

[88]  T. Motoyama,et al.  Promoter hypermethylation of tumor suppressor and tumor‐related genes in non‐small cell lung cancers , 2003, Cancer science.

[89]  B. Cairns Emerging roles for chromatin remodeling in cancer biology. , 2001, Trends in cell biology.

[90]  Zohar Yakhini,et al.  Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.

[91]  M. Guo,et al.  Epigenetic changes in colorectal cancer , 2013, Chinese journal of cancer.

[92]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[93]  Jon Penterman,et al.  DEMETER DNA Glycosylase Establishes MEDEA Polycomb Gene Self-Imprinting by Allele-Specific Demethylation , 2006, Cell.

[94]  Joanna R. Morris,et al.  BRCA1 methylation: a significant role in tumour development? , 2002, Seminars in cancer biology.

[95]  Sandya Liyanarachchi,et al.  Aberrant DNA Methylation of OLIG1, a Novel Prognostic Factor in Non-Small Cell Lung Cancer , 2007, PLoS medicine.

[96]  Hein Putter,et al.  Persistent epigenetic differences associated with prenatal exposure to famine in humans , 2008, Proceedings of the National Academy of Sciences.

[97]  Eva K. Lee,et al.  Predicting aberrant CpG island methylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[98]  R. Oakey,et al.  Imprinted genes: identification by chromosome rearrangements and post-genomic strategies. , 2002, Trends in genetics : TIG.

[99]  R. Adams,et al.  S-adenosylmethionine metabolism in herpes simplex virus type 2-infected cells. , 1993, The Journal of general virology.

[100]  A. Bhagwat,et al.  Reviving a dead enzyme: cytosine deaminations promoted by an inactive DNA methyltransferase and an S-adenosylmethionine analogue. , 2000, Biochemistry.

[101]  R. Löwer,et al.  DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas , 1999, British Journal of Cancer.

[102]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[103]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[104]  Manel Esteller,et al.  MicroRNAs and cancer epigenetics: a macrorevolution , 2010, Current opinion in oncology.

[105]  Z. Herceg,et al.  Epigenetic drivers and genetic passengers on the road to cancer. , 2008, Mutation research.

[106]  G. Pfeifer,et al.  GADD45A Does Not Promote DNA Demethylation , 2008, PLoS genetics.

[107]  M. Widschwendter,et al.  CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients , 2004, International journal of cancer.

[108]  Trygve O Tollefsbol,et al.  The impact of metabolism on DNA methylation. , 2005, Human molecular genetics.

[109]  A. Feinberg,et al.  The history of cancer epigenetics , 2004, Nature Reviews Cancer.

[110]  Z. Herceg,et al.  Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. , 2010, Cancer research.

[111]  V. Colot,et al.  Eukaryotic DNA methylation as an evolutionary device , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[112]  J. Herman,et al.  DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. , 2001, Human molecular genetics.

[113]  J. Wilkins,et al.  Genomic imprinting and methylation: epigenetic canalization and conflict. , 2005, Trends in genetics : TIG.

[114]  F. Wright,et al.  Global methylation profiling of lung cancer identifies novel methylated genes. , 2001, Neoplasia.

[115]  M. Szyf,et al.  A mammalian protein with specific demethylase activity for mCpG DNA , 1999, Nature.

[116]  S. Hirohashi,et al.  Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues , 2006, International journal of cancer.

[117]  M. Vairapandi,et al.  Enzymic removal of 5-methylcytosine from DNA by a human DNA-glycosylase. , 1993, Nucleic acids research.

[118]  J. Flanagan,et al.  Genome-wide hypomethylation in cancer may be a passive consequence of transformation. , 2010, Biochimica et biophysica acta.

[119]  R. O’Neill,et al.  Undermethylation associated with retroelement activation and chromosome remodelling in an interspecific mammalian hybrid , 1998, Nature.

[120]  Y. Liaw,et al.  Genome-wide hypomethylation in hepatocellular carcinogenesis. , 2001, Cancer research.

[121]  David Garrick,et al.  Repeat-induced gene silencing in mammals , 1998, Nature Genetics.

[122]  A. Feinberg,et al.  Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice , 2005, Science.

[123]  W. Reik,et al.  Epigenetic Reprogramming in Mammalian Development , 2001, Science.

[124]  J. Minna,et al.  Aberrant promoter methylation of multiple genes in non-small cell lung cancers. , 2001, Cancer research.

[125]  M. Esteller Epigenetic changes in cancer , 2011, F1000 biology reports.

[126]  C. Walsh,et al.  Association of Dnmt3a and thymine DNA glycosylase links DNA methylation with base-excision repair , 2006, Nucleic acids research.

[127]  P. Laird Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[128]  Alexander W. Bird,et al.  Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair , 2002, Nature.

[129]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[130]  C. Plass,et al.  Genome-wide analysis of DNA methylation changes in human malignancies. , 2006, Current topics in microbiology and immunology.

[131]  J. Herman,et al.  Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer. , 2006, Cancer research.

[132]  A. Michie,et al.  Death‐associated protein kinase (DAPK) and signal transduction: regulation in cancer , 2010, The FEBS journal.

[133]  Manel Esteller,et al.  Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. , 2003, Cancer research.

[134]  M. Fontecave,et al.  S-adenosylmethionine: nothing goes to waste. , 2004, Trends in biochemical sciences.

[135]  J. Minna,et al.  Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer , 2003, International journal of cancer.

[136]  Paolo Vineis,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[137]  W. Franklin Premalignant evolution of lung cancer: Gilles F Filley lecture. , 2004, Chest.

[138]  Xiaodong Cheng,et al.  Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation , 2007, Nature.

[139]  S. Petruk,et al.  Regulatory noncoding RNAs at Hox loci. , 2009, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[140]  S. Zeisel Importance of methyl donors during reproduction. , 2009, The American journal of clinical nutrition.

[141]  H. Drexler Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cells , 1998, Leukemia.

[142]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[143]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[144]  A. Razin,et al.  Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. , 1992, Genes & development.

[145]  Sean V. Tavtigian,et al.  Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical Predictors , 2010, PloS one.

[146]  Sang-Woon Choi,et al.  Gene-nutrient interactions and DNA methylation. , 2002, The Journal of nutrition.

[147]  A. Rosenthal,et al.  Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[148]  Lizzie Buchen Neuroscience: In their nurture , 2010, Nature.

[149]  A. Bird,et al.  Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. , 2001, Genes & development.

[150]  Z. Herceg,et al.  DNA methylation and cancer: ghosts and angels above the genes , 2011, Current opinion in oncology.

[151]  W. Franklin,et al.  Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum , 2007, British Journal of Cancer.

[152]  G. Watanabe,et al.  Different histological types of non‐small cell lung cancer have distinct folate and DNA methylation levels , 2009, Cancer science.

[153]  M. Siegmann,et al.  Demethylation of DNA by purified chick embryo 5-methylcytosine-DNA glycosylase requires both protein and RNA. , 1997, Nucleic acids research.

[154]  K. Robertson DNA methylation and human disease , 2005, Nature Reviews Genetics.

[155]  I. Weaver,et al.  Maternal care, the epigenome and phenotypic differences in behavior. , 2007, Reproductive toxicology.

[156]  A. Cassidy,et al.  Hypomethylation of retrotransposable elements correlates with genomic instability in non‐small cell lung cancer , 2009, International journal of cancer.

[157]  M. Surani,et al.  Genomic Imprinting, Mammalian Evolution, and the Mystery of Egg-Laying Mammals , 2000, Cell.

[158]  H. Osada,et al.  Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer , 2002, Oncogene.

[159]  J. Finkelstein,et al.  Methionine metabolism in mammals. , 1990, The Journal of nutritional biochemistry.

[160]  Xueyan Zhong,et al.  High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer , 2008, Proceedings of the National Academy of Sciences.

[161]  A. Bird,et al.  The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites , 1999, Nature.

[162]  P. Molloy,et al.  DNA hypomethylation and human diseases. , 2007, Biochimica et biophysica acta.

[163]  A. Niveleau,et al.  DNA methyltransferases in normal and avian sarcoma virus-transformed rat cells. Quantitation of 5-methyldeoxycytidine in DNA and enzyme kinetics study. , 1985, Biochimica et biophysica acta.

[164]  T. Rauch,et al.  DNA methylation patterns in lung carcinomas. , 2009, Seminars in cancer biology.

[165]  Chun Xing Li,et al.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.

[166]  Susan J. Clark,et al.  CpNpG methylation in mammalian cells , 1995, Nature Genetics.

[167]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[168]  Zdenko Herceg,et al.  Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. , 2007, Mutagenesis.

[169]  D. Ford,et al.  Could Sirt1-mediated epigenetic effects contribute to the longevity response to dietary restriction and be mimicked by other dietary interventions? , 2009, AGE.

[170]  E. Mark,et al.  p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. , 2001, Cancer research.

[171]  Apiwat Mutirangura,et al.  Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis , 2004, Oncogene.

[172]  Keith D Robertson,et al.  DNA methylation, methyltransferases, and cancer , 2001, Oncogene.

[173]  Juri Rappsilber,et al.  TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity , 2011, Nature.

[174]  P. Geyer,et al.  Faculty Opinions recommendation of A role for the elongator complex in zygotic paternal genome demethylation. , 2010 .

[175]  R. Jaenisch,et al.  Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[176]  Hubert Vesselle,et al.  DNA Methylation in Tumor and Matched Normal Tissues from Non-Small Cell Lung Cancer Patients , 2008, Cancer Epidemiology Biomarkers & Prevention.

[177]  David I. K. Martin,et al.  Retrotransposons as epigenetic mediators of phenotypic variation in mammals , 2001, Nature Genetics.

[178]  B. Stewart,et al.  World Cancer Report , 2003 .

[179]  W. Reik Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.

[180]  J. Herman,et al.  Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. , 2006, Cancer research.

[181]  P. Shields,et al.  Molecular epidemiology of lung cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[182]  C. Kunz,et al.  The enigmatic thymine DNA glycosylase. , 2007, DNA repair.

[183]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[184]  M. Szyf,et al.  Replacement of 5-methylcytosine by cytosine: a possible mechanism for transient DNA demethylation during differentiation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[185]  Z. Fuks,et al.  Engaging the vascular component of the tumor response. , 2005, Cancer cell.

[186]  W. Gerald,et al.  A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies , 2006, PLoS medicine.

[187]  A. Feinberg,et al.  Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.

[188]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[189]  G. Ming,et al.  DNA excision repair proteins and Gadd45 as molecular players for active DNA demethylation , 2009, Cell cycle.

[190]  W. Lissens,et al.  De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes , 2005, Human mutation.

[191]  Shirley M. Tilghman,et al.  CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus , 2000, Nature.

[192]  E Gabrielson,et al.  Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[193]  Rudolf Jaenisch,et al.  DNA hypomethylation leads to elevated mutation rates , 1998, Nature.

[194]  D. Rigal,et al.  Methylation patterns of long interspersed repeated DNA and alphoid repetitive DNA from human cell lines and tumors. , 1992, Anticancer research.

[195]  K. Robertson,et al.  DNMT1 knockout delivers a strong blow to genome stability and cell viability , 2007, Nature Genetics.

[196]  K. Schuebel,et al.  Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation. , 2006, Cancer research.

[197]  S. Belinsky,et al.  Gene-promoter hypermethylation as a biomarker in lung cancer , 2004, Nature Reviews Cancer.

[198]  M. Fraga,et al.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.

[199]  Lee E. Edsall,et al.  Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.

[200]  Adrian Bird,et al.  Perceptions of epigenetics , 2007, Nature.

[201]  T. Bestor,et al.  The Colorful History of Active DNA Demethylation , 2008, Cell.

[202]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[203]  B. Cairns,et al.  DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45 , 2008, Cell.

[204]  D. Heimburger,et al.  DNA methylation and diet in cancer. , 2002, The Journal of nutrition.

[205]  G. Pfeifer,et al.  The tumor suppressor RASSF1A in human carcinogenesis: an update. , 2005, Histology and histopathology.

[206]  Christof Niehrs,et al.  Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation , 2007, Nature.

[207]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[208]  BY G. L. CANTONIt METHYLATION OF NICOTINAMIDE WITH A SOLUBLE ENZYME SYSTEM FROM RAT LIVER* , 2003 .

[209]  Yue-zhong Wu,et al.  Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing , 2007, BMC Genomics.

[210]  Christoph Plass,et al.  Lung cancer epigenetics and genetics , 2008, International journal of cancer.

[211]  K. Verstrepen,et al.  Timescales of Genetic and Epigenetic Inheritance , 2007, Cell.

[212]  B. Tycko,et al.  Epigenetic gene silencing in cancer. , 2000, The Journal of clinical investigation.

[213]  J. Herman,et al.  Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. , 2002, Cancer research.

[214]  Y. Shim,et al.  Aberrant methylation of H‐cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma , 2005, Cancer.

[215]  M. Batzer,et al.  The impact of retrotransposons on human genome evolution , 2009, Nature Reviews Genetics.

[216]  R. Ueda,et al.  Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. , 1995, Oncogene.

[217]  J. Herman,et al.  hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. , 1999, The American journal of pathology.

[218]  C. Walsh,et al.  Cytosine methylation and the ecology of intragenomic parasites. , 1997, Trends in genetics : TIG.

[219]  T. Ghosh,et al.  Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development , 2008, Cancer and Metastasis Reviews.

[220]  Z. Herceg,et al.  Epigenetic signatures in cancer: Implications for the control of cancer in the clinic. , 2010, Current opinion in molecular therapeutics.

[221]  S. Hirohashi,et al.  DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. , 2006, Carcinogenesis.

[222]  S. Henikoff,et al.  DNA demethylation by DNA repair. , 2009, Trends in genetics : TIG.

[223]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.

[224]  W. Johnson,et al.  DNA Demethylase Activity Maintains Intestinal Cells in an Undifferentiated State Following Loss of APC , 2010, Cell.

[225]  A. Ferguson-Smith,et al.  Epigenetics: Perceptive enzymes , 2007, Nature.

[226]  F. Costa,et al.  Non-coding RNAs: new players in eukaryotic biology. , 2005, Gene.

[227]  J. Herman,et al.  Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. , 2003, Cancer cell.

[228]  J. Simon,et al.  Roles of the EZH2 histone methyltransferase in cancer epigenetics. , 2008, Mutation research.

[229]  E. Li Chromatin modification and epigenetic reprogramming in mammalian development , 2002, Nature Reviews Genetics.

[230]  K. Robertson,et al.  DNA methylation in development and human disease. , 2008, Mutation research.

[231]  A. Ferguson-Smith,et al.  CG dinucleotide periodicities recognized by the Dnmt3a–Dnmt3L complex are distinctive at retroelements and imprinted domains , 2009, Mammalian Genome.